STOCK TITAN

International Flavors & Fragrances Inc. - IFF STOCK NEWS

Welcome to our dedicated page for International Flavors & Fragrances news (Ticker: IFF), a resource for investors and traders seeking the latest updates and insights on International Flavors & Fragrances stock.

International Flavors & Fragrances Inc. (IFF) is a leading innovator in creating sensorial experiences that drive the world of flavors and fragrances. Headquartered in New York, the company partners with customers globally to develop unique products for the food, beverage, health, personal care, and household goods industries. With a strong commitment to discovery and innovation, IFF continuously explores new possibilities in both fine fragrances and beauty, as well as in beloved foods and beverages.

IFF's core businesses include the Nourish segment, which accounts for nearly half of its revenue. This segment specializes in producing flavors, texturants, and plant-based proteins, providing essential ingredients that enhance the appeal and functionality of food products. Additionally, the Health & Biosciences division, generating roughly one-fourth of the company's revenue, is renowned for its expertise in probiotics and enzymes, making significant contributions to health and wellness solutions.

The company leverages its global team of 7,300 professionals along with leading consumer insights, research and development, and creative expertise to deliver differentiated products. Their proprietary formulations and custom solutions are a testament to their innovative approach and customer-centric focus.

IFF has recently made remarkable advancements in excipient technology, presenting its comprehensive range at global events such as CPhI Japan 2024 and Vitafoods Europe 2024. These showcases highlight the company's commitment to driving pharmaceutical innovation, with notable products like METHOCEL™, ETHOCEL™, and POLYOX™ under its new controlled release platform, 'Timing is Everything'. This new platform emphasizes the importance of controlled release in pharmaceutical therapies, aiming to improve patient compliance and treatment efficacy.

IFF continues to expand its innovative offerings and partnerships, demonstrating a significant impact across various industries. The company's dedication to sustainability and precision in science and creativity positions it as a key player in transforming everyday experiences and contributing to a better world.

For more detailed information about their latest projects and developments, visit their official website at iff.com.

Rhea-AI Summary
IFF's Pharma Solutions division will showcase its portfolio of excipients and present proprietary research at AAPS 2023 PharmSci 360. The research findings will address formulation challenges and highlight innovation possibilities. IFF will demonstrate its commitment to helping customers overcome formulation challenges. The company's scientific posters will cover excipient variability and offer insights on achieving solubility and stability in oral tablet formulations. IFF will also feature its low nitrite excipient portfolio at the event.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.54%
Tags
none
-
Rhea-AI Summary
IFF's Pharma Solutions division will showcase new products and innovations at CPHI 2023 in Barcelona. They will present Avicel PH LN, a low nitrite microcrystalline cellulose that reduces nitrosamine formation in drugs. IFF is also launching METHONOVA, a cell-compatible methylcellulose for biotech industries. The company is expanding its production facility in Thailand to meet growing demand.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.46%
Tags
none
-
Rhea-AI Summary
IFF's Pharma Solutions and Health teams will showcase their plant-based dietary supplement solutions and innovative products at SupplySide West Expo. Their groundbreaking carrageenan-free vegan softgel technology, VERDIGEL™ SC, enables manufacturers to meet growing demand for clean label, vegetarian supplements. IFF's comprehensive platform of solutions for vegan softgels, including VERDIGEL™ SC, SeaGel®, and Aquateric® N100, offers significant labeling advantages. Additionally, IFF offers expertise in plant-based gummy formulation and cellulose-based binders. Visitors can explore turnkey capabilities for unique formulations and personalized nutrition.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.15%
Tags
none
Rhea-AI Summary
IFF showcases portfolio of functional ingredients and flavors at Food Tech Summit & Expo in Mexico City
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.67%
Tags
none
-
Rhea-AI Summary
IFF CEO to participate in fireside chat at Barclays Global Consumer Staples Conference on Sept. 7, 2023 at 9:00 a.m. ET.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.75%
Tags
conferences
-
Rhea-AI Summary
IFF (NYSE: IFF) completed its new North American Creation and Design center in New Century, integrating flavor and ingredient product development capabilities. The facility expansion includes new labs for sweet and savory flavors, dairy, bars, culinary, bakery, and pet food development. This investment strengthens IFF's end-to-end IFF PRODUCT DESIGN™ approach, offering a breadth of knowledge and resources across multiple food categories.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.6%
Tags
none
News
Rhea-AI Summary
IFF (NYSE: IFF) reported strong top- and bottom-line growth in its Scent and Pharma Solutions segments, but experienced softness in its Functional Ingredients business due to customer destocking. The company is strengthening its capital structure through working capital improvements and portfolio optimization, including the sale process for Lucas Meyer Cosmetics. IFF declared a dividend for the third quarter of 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-19.37%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.42%
Tags
none
-
Rhea-AI Summary
IFF (NYSE:IFF) has completed the divestiture of its Flavor Specialty Ingredients (FSI) business to Exponent, a UK-based private equity firm. The sale was finalized on August 1, 2023. This move is part of IFF's strategy to optimize its portfolio and improve growth and returns. The company aims to concentrate on its most attractive businesses and reduce outstanding debt.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.35%
Tags
none
Rhea-AI Summary
IFF (NYSE:IFF) to Release Q2 2023 Earnings Results; Live Webcast on August 8, 2023. IFF, a leader in food, beverage, health, biosciences, and scent, will discuss results and outlook with investors. Access the webcast on ir.iff.com. Company's focus on creating essential solutions for a better world highlighted.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.34%
Tags

FAQ

What is the current stock price of International Flavors & Fragrances (IFF)?

The current stock price of International Flavors & Fragrances (IFF) is $90.81 as of November 22, 2024.

What is the market cap of International Flavors & Fragrances (IFF)?

The market cap of International Flavors & Fragrances (IFF) is approximately 23.0B.

What does International Flavors & Fragrances Inc. (IFF) do?

IFF is a global leader in creating flavors and fragrances for the food, beverage, health, personal care, and household goods industries.

What are the core business segments of IFF?

IFF's core business segments include Nourish, which produces flavors and plant-based proteins, and Health & Biosciences, known for probiotics and enzymes.

Where is IFF headquartered?

IFF is headquartered in New York, USA.

How many employees does IFF have?

IFF employs approximately 7,300 professionals globally.

What are some recent innovations by IFF?

IFF has recently launched a new controlled release platform named 'Timing is Everything' and showcased advanced excipient technologies at global events.

What is the significance of the 'Timing is Everything' platform?

The 'Timing is Everything' platform emphasizes the importance of controlled release in pharmaceuticals, improving patient compliance and treatment efficacy.

How does IFF support the food industry?

The Nourish segment of IFF provides flavors, texturants, and plant-based proteins that enhance the appeal and functionality of food products.

What role does IFF play in the health sector?

IFF's Health & Biosciences division is a global leader in probiotics and enzymes, contributing significantly to health and wellness solutions.

Where can I find more information about IFF's products and services?

For more information about IFF’s products and services, visit their official website at http://www.iff.com.

What is IFF's approach to innovation?

IFF embraces a passion for discovery, continuously exploring new possibilities to co-create unique scents and tastes in various industries.

International Flavors & Fragrances Inc.

NYSE:IFF

IFF Rankings

IFF Stock Data

23.05B
255.53M
0.06%
93.66%
1.41%
Specialty Chemicals
Industrial Organic Chemicals
Link
United States of America
NEW YORK